Light Exposure for Insomnia
(NASC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how exposure to bright light, also known as Bright Light Therapy or Phototherapy, might improve sleep quality and cognitive function in older adults with insomnia. Participants will use light glasses twice a day for about a month to determine if this enhances daytime activity, potentially leading to better sleep and mental sharpness. Individuals who have experienced insomnia for at least four weeks, often wake up too early, and spend more than an hour awake during the night may be suitable for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance sleep and cognitive health.
Will I have to stop taking my current medications?
The trial requires that you stop taking certain medications, including psychoactive, hypnotic, stimulant, or analgesic medications, as well as those affecting the noradrenergic system like B-blockers, SNRIs, and NDRIs. If you are on any of these, you would need to stop using them to participate.
What prior data suggests that light exposure is safe for treating insomnia?
Research has shown that bright light therapy is generally safe for most people. Studies have found that it can improve sleep and mood without causing serious side effects. One review found it significantly increased sleep time and quality. Another study highlighted its ability to enhance sleep and reduce symptoms of depression.
While bright light therapy is usually well-tolerated, some people might experience minor effects like eye strain or headaches. The treatment involves wearing special light glasses, designed to be safe. Participants will be monitored for any side effects and will keep diaries to track their experiences. Overall, bright light therapy is considered a promising and safe option for those looking to improve sleep quality.12345Why are researchers excited about this trial?
Researchers are excited about using bright light exposure to treat insomnia because it offers a non-drug approach that targets the body's natural sleep-wake cycle. Unlike medications or behavioral therapies that are standard for insomnia, bright light exposure specifically aims to regulate melatonin production through timed exposure to light with a green-blue wavelength. This method is unique because it directly influences biological functions associated with light exposure, potentially offering a safer option with fewer side effects than traditional insomnia treatments.
What evidence suggests that light exposure might be an effective treatment for insomnia?
This trial will compare bright light therapy with dim red light exposure for individuals with insomnia. Research has shown that bright light therapy can improve sleep and mood. Studies indicate it can increase total sleep time by about 32 minutes and enhance sleep quality throughout the night. Light therapy has also reduced daytime sleepiness and fatigue. By influencing sleep patterns and the body clock, it may boost mood. While not a complete solution, these findings suggest bright light therapy could be promising for those dealing with insomnia.13567
Who Is on the Research Team?
Daniela Grimaldi, MD, PhD
Principal Investigator
Northwestern University
Phyllis C Zee, MD, PhD
Principal Investigator
Northwestern University
Are You a Good Fit for This Trial?
This trial is for older adults who have trouble sleeping, known as insomnia. Participants should be at risk for memory-related diseases but can't join if they don't match the age and sex criteria or have other factors that could affect the study results.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive daily exposure to bright light or dim red light for 28 (+4) days, with weekly phone calls to monitor compliance and side effects
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Light Exposure
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator